Showing 101-110 of 3024 results for "".
- Keeping Tysabri Therapy on Targethttps://practicalneurology.com/columns/practice-management/keeping-tysabri-therapy-on-target/31170/Natalizumab (Tysabri) in Multiple Sclerosis: Balancing Efficacy and SafetyOne year following its reintroduction to the market, natalizumab (Tysabri) continues to be a focal point for multiple sclerosis (MS) specialists striving to optimize its use while mitigating associated risks. Originally withdr
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31317/Practical Neurology Summary – May 2006Recent advancements and studies in neurology highlight significant progress in treating multiple sclerosis (MS), stroke management, neurodegenerative diseases, and sleep disorders, providing valuable insights for healthcare professionals.A pivotal study involvin
Study Spotlight: Clarifying the Link Between Sleep Disturbance and Cognitive Decline
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/study-spotlight-clarifying-the-link-between-sleep-disturbance-and-cognitive-decline/30417/A Q&A with Alberto Rafael Ramos, MD and Clinton Wright, MD- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31337/Recent Advances and Insights in Neurology PracticeIn the dynamic field of neurology, several significant developments have emerged, offering new perspectives and treatment options for healthcare professionals. Notably, natalizumab (Tysabri), a therapy for multiple sclerosis (MS), may soon return to
Case Report: Progressive Muscle Weakness
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-progressive-muscle-weakness/31208/Arjun Seth, MD and Quiha Fan, MD detail a notable case report involving progressive muscle weakness from presentation, through diagnosis, to resolution.Video-Case Report: Progressive Neuropathy With Cerebellar Ataxia
https://practicalneurology.com/diseases-diagnoses/stroke/video-case-report-progressive-neuropathy-withcer/31109/Investigation of antibody titers is essential for patients who have neuropathy with cerebellar ataxia and do not respond to IVIG treatment. By Asseel Albayati, MD; Safa AlJammali, MD; Mohammed AlKhero, MD; and Aziz Shaibani, MD CASE Clinical Presentation A woman, age 28, presented with inability toAbout the Cover Artist: Fatherhood by Bevan Choate, MD
https://practicalneurology.com/diseases-diagnoses/stroke/about-the-cover-artistifatherhoodi-by-bevan-choate-md/32198/Dr. Choate, a practicing urologist, turned to art while recovering from a stroke he experienced at age 35. He continues to use his art to advocate for those affected by brain injury.- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31049/Effective income distribution is crucial for maintaining harmony and productivity within neurology practices. In "Sharing the Wealth: Six Methods of Partner Income Distribution," Derek A. Preece, MBA, explores various compensation models that can either foster collaboration or fuel conflict among pr
Medication-Overuse Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/medication-overuse-headache/30281/Questions and answers from Nina Tsakadze, MD, PhD; Natasha Antonovich; PharmD; and Fabian Rossi, MDUpdate on Noninvasive Neuromodulation Devices for Headache Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/update-on-noninvasive-neuromodulation-devices-for-headache-treatment/31283/Stewart J. Tepper, MD, Vice President of the New England Institute for Neurology and Headache, Peter McAllister, MD, FAAN, Chief Medical Officer of the New England Institute for Neurology and Headache, and Teshamae Monteith, MD, Associate Professor and Chief of the Headache Division of the Departmen